$331.57
At close: May 21, 5:00 PM EST
$330.90
-0.67-0.20%
After Hours: 4:54 PM EST
Amgen Inc Stock Guidance
AMGNNASDAQ
Dividend: The dividend Ex-Date was 6 days ago
Amgen (AMGN) last issued guidance on April 30, 2026 for fiscal year 2026. The company guided earnings per share in the range of $21.70 - $23.10, compared to a consensus EPS estimate of $22.29. Amgen also guided revenue in the range of $37.10B - $38.50B for the period.
Compared to prior guidance, Amgen maintained its EPS outlook from a previous range of $21.60 - $23.00. On the revenue side, the company maintained its revenue forecast from a prior range of $37.00B - $38.40B.
Amgen has issued 16 guidance updates between August 4, 2022 and April 30, 2026. During this period, the company raised its outlook 6 times, reflecting management's growing confidence in business performance.
Latest Guidance Date
Apr 30, 2026
Guidance Period
Full Year 2026
EPS Guidance Range
$21.70 - $23.10
Revenue Guidance Range
$37.10B - $38.50B
Amgen Guidance History
Review all historical guidance issued by Amgen, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Amgen (AMGN)?
The most recent guidance for Amgen (AMGN) was reported on April 30, 2026 for the fiscal year 2026. The company provided earnings per share guidance in the range of $21.70 to $23.10, compared to the estimated EPS of $22.29. Additionally, Amgen forecasted revenue between $37.10B and $38.50B for the period.
What EPS range did Amgen (AMGN) guide for?
Amgen (AMGN) guided EPS in the range of $21.70 to $23.10 for the fiscal year 2026. The consensus analyst EPS estimate is $22.29.
What revenue range did Amgen (AMGN) guide for?
Amgen (AMGN) guided revenue in the range of $37.10B to $38.50B for the fiscal year 2026.
Did Amgen (AMGN) raise or lower guidance?
Amgen (AMGN) maintained its EPS guidance from a prior range of $21.60 - $23.00 to $21.70 - $23.10 for the fiscal year 2026.
When did Amgen (AMGN) last issue guidance?
Amgen (AMGN) last issued guidance on April 30, 2026 for the fiscal year 2026.
